209 related articles for article (PubMed ID: 29696364)
21. Nestin expression in astrocytic tumors delineates tumor infiltration.
Kitai R; Horita R; Sato K; Yoshida K; Arishima H; Higashino Y; Hashimoto N; Takeuchi H; Kubota T; Kikuta K
Brain Tumor Pathol; 2010 Apr; 27(1):17-21. PubMed ID: 20425043
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary.
Soukup J; Kasparova P; Kohout A; Rychly B; Skarkova V; Syrucek M; Gabalec F
Pituitary; 2019 Feb; 22(1):70-78. PubMed ID: 30607746
[TBL] [Abstract][Full Text] [Related]
23. High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients.
Li WQ; Zhong NZ; He J; Li YM; Hou LJ; Liu HM; Xia CY; Wang LZ; Lu YC
Oncol Rep; 2017 May; 37(5):2865-2874. PubMed ID: 28339043
[TBL] [Abstract][Full Text] [Related]
24. Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas.
Komatani H; Sugita Y; Arakawa F; Ohshima K; Shigemori M
Int J Oncol; 2009 Mar; 34(3):665-72. PubMed ID: 19212671
[TBL] [Abstract][Full Text] [Related]
25. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
[TBL] [Abstract][Full Text] [Related]
26. Expression of variant CD44 epitopes in human astrocytic brain tumors.
Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
[TBL] [Abstract][Full Text] [Related]
27. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
Thotakura M; Tirumalasetti N; Krishna R
J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
29. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of the expression of the RCAS1 mRNA and protein in astrocytic tumors].
Shen CF; Yuan XR; Qin ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):836-9. PubMed ID: 18007080
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
[TBL] [Abstract][Full Text] [Related]
32. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
33. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
[TBL] [Abstract][Full Text] [Related]
35. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
36. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.
Stevenson CB; Ehtesham M; McMillan KM; Valadez JG; Edgeworth ML; Price RR; Abel TW; Mapara KY; Thompson RC
Neurosurgery; 2008 Sep; 63(3):560-9; discussion 569-70. PubMed ID: 18812968
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
39. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.
Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME
Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454
[TBL] [Abstract][Full Text] [Related]
40. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis.
Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K
Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
